Ironwood Pharmaceuticals
IRWD
#7014
Rank
C$0.98 B
Marketcap
C$5.99
Share price
6.17%
Change (1 day)
417.44%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): C$0.23 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are C$0.36 Billion. In 2025 the company made an earning of C$97.49 Million, an increase over its 2024 earnings that were of C$90.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.23 B143.5%
2025 C$97.49 M7.4%
2024 C$90.77 M-106.88%
2023 -C$1.32 Billion-475.59%
2022 C$0.35 B25.8%
2021 C$0.27 B84.32%
2020 C$0.15 B84.69%
2019 C$82.06 M-125.13%
2018 -C$0.33 Billion100.62%
2017 -C$0.17 Billion43.12%
2016 -C$0.12 Billion-42.73%
2015 -C$0.2 Billion-24.76%
2014 -C$0.27 Billion-30.49%
2013 -C$0.38 Billion275.65%
2012 -C$0.11 Billion11.56%
2011 -C$90.64 Million9.38%
2010 -C$82.87 Million-15.21%
2009 -C$97.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
C$20.41 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-C$0.22 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA